Clinical trial
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow…
NCT00408382 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00408382 |
|---|---|
| Title | Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesteremia, Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | atorvastatin, Lipitor |
| Enrollment | 50 |
| First posted | Dec 6, 2006 |
| Last update posted | Nov 17, 2011 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: